Deloitte names Kneat third fastest growing tech company in Ireland


LIMERICK, Ireland, December 9, 2021 / CNW / – kneat.com, inc. (TSX: KSI) (“Kneat or the Company”) a leader in the digitization and automation of validation and quality processes, is happy to announce that it has been ranked 3e in the prestigious 2021 list of Deloitte Ireland Technology Fast 50.

The Deloitte Technology Fast 50 Awards is one of ireland first and foremost technology rewards programs. With Kneat’s operational headquarters in Limerick, Ireland, the company was included in the ranking of the 50 fastest growing technology companies in the country, based on four-year revenue growth through December 2020. During this period, Kneat experienced growth by 1,661%, while its workforce increased by 350%.

In addition to coming third overall, Kneat also received second prize for the Scale-Up Award, given to companies that have demonstrated an impressive ability to grow and expand overseas.

“We are thrilled with these awards and to be shortlisted along with so many other exceptional companies. We would like to thank Deloitte, our customers, partners, shareholders and our outstanding and high performing global teams, ”said Eddie ryan, CEO of Kneat. “This makes our team very proud of the fact that among our many customers, we help seven of the world’s 10 largest pharmaceutical companies and three of the world’s leading COVID-19 vaccine manufacturers deliver their drugs to the highest quality standards. Ryan continued.

This award closes a year that included several milestones such as a public equity funding round of over $ 20 million CAD in April, continued acquisition and expansion of key biopharmaceutical customers, record revenue growth achievements and the Company’s recent listing on the Toronto Stock Exchange.

Read more about Kneat’s accomplishments in 2021 here.

About Kneat

Kneat, a Canadian company with operational headquarters in Limerick, Ireland, develops and markets the next generation Kneat Gx software platform. Several business work processes can be configured on the platform, from equipment validation to IT system validation, including quality document management.

Kneat’s software enables users to create, review, approve, run tests online, manage exceptions, and publish final deliverables in a controlled platform that complies with FDA 21 CFR Part 11 / Eudralex Annex 11. Macro and micro report dashboards enable powerful monitoring of all systems, projects and processes on a global scale.

Customer case studies report productivity improvements of over 100% and a higher standard of data integrity and compliance. For more information, visit www.kneat.com.

Cautions and forward-looking statements

With the exception of the statements of historical fact contained in this document, certain information presented constitutes “forward-looking information” within the meaning of applicable Canadian securities laws. This forward-looking information includes, but is not limited to, the relationship between Kneat and the customer, Kneat’s business development activities, the timeframes for using and implementing Kneat’s software as part of the customer’s validation processes. , the ability and intent of the client to tailor the use of Kneat’s software within the client’s organization and the compliance of Kneat’s platform for regulatory audits and inspections. While these forward-looking statements are expressed by Kneat, as set forth in this press release, in good faith and believed by Kneat to have a reasonable basis, they are subject to significant risks and uncertainties. As a result of these risks and uncertainties, the events predicted in these forward-looking statements may differ materially from actual results or events.

These forward-looking statements are not guarantees of future performance, as they involve risks and uncertainties. The forward-looking information contained in this press release does not include a full assessment or reflection of the unprecedented impacts of the COVID-19 pandemic occurring since the first quarter of 2020 and of the ongoing and developing global and regional indirect economic impacts that result. This has resulted in significant economic uncertainty and although the Company has not to date suffered any significant impact on its operations, any potential impact on our future is difficult to understand or measure at this time.

Kneat does not undertake any obligation to publish revisions to any forward-looking statement, except as may be required under applicable securities laws. Investors should not assume that the failure to update a previously published forward-looking statement constitutes a reaffirmation of that statement. The continued reliance on forward-looking statements is at the risk and peril of the investors.

SOURCE kneat.com, inc.

For more information: Hugh Kavanagh, CFO, T: +353 61 203826, E: [email protected]m; James Bowen, Kneat Investor Relations, T: +1 416-519-9442, E: [email protected]

Related links

https://www.kneat.com/


Comments are closed.